United Therapeutics CorporationUTHR

NASDAQHealthcareBiotechnology$536.12+0.62%

A biotechnology company focused on developing and commercializing therapies for pulmonary arterial hypertension and other rare diseases. Its revenue is largely driven by a portfolio of PAH treatments, while the company invests heavily in next‑generation platforms including organ manufacturing and re...

Market Cap: $23.5B52W Range: $266.98 – $548.12

This page tracks all publicly disclosed congressional trades in United Therapeutics Corporation (UTHR), a company in the Healthcare sector. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.

Total Disclosures

Unique Politicians

Buys

Sells

Congressional Trading History

No congressional trades found for this stock.

All stocks traded by Congress Full trade feed Most active traders About the STOCK Act Report missing trade

United Therapeutics CorporationUTHR

Congressional Trading History

Related